Abstract
Opioid and marijuana use during pregnancy has received increased attention over time; however, there is still much unknown about the effect of in utero exposure to opiates and marijuana on child development. The current chapter outlines evidence suggesting that prenatal opioid exposure is linked to decreased neurobehavioral development in infants, challenges associated with neonatal abstinence syndrome, and potential behavioral concerns such as inattention and hyperactivity later in childhood. Marijuana exposure has been less studied; however, there is some evidence to suggest such exposure is linked to deficits later in childhood, such as decreased attention span and short-term memory skills. Implications for intervention/prevention and school-based accommodations are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Anyategbunam, A., Tran, T., Jadali, D., Randolph, G., & Mikhail, M. (1997). Assessment of fetal well-being in methadone-maintained pregnancies: Abnormal nonstress tests. Gynecologic and Obstetric Investigation, 43, 25–28.
Azadi, A., & Dildy, G. (2008). Universal screening for substance abuse at the time of parturition. American Journal of Obstetrics & Gynecology, 198, 30–32. doi:10.1016/j/ajog.2007.10.780.
Baldacchino, A., Arbuckle, K., Petrie, D., & McCowan, C. (2014). Neurobehavioral consequences of chronic intrauterine opioid exposure in infants and preschool children: A systematic review and meta-analysis. BMC Psychiatry, 14, 104–116. doi:10.1186/1471-244X-14-104.
Beckwith, A., & Burke, S. (2015). Identification of early developmental deficits in infants with prenatal heroin, methadone, and other opioid exposure. Clinical Pediatrics, 54, 328–335. doi:10.1177/0009922814549545.
Cohen, M., Johnston, P., Ehlkes, T., Fulham, R., Ward, P., Thienel, R., … Schall, U. (2015). Functional magnetic resonance brain imaging of executive cognitive performance in young first episode schizophrenia patients and age-matched long-term cannabis users. Neurology, Psychiatry, and Brain Research, 21, 51–62. doi:10.1016/j.npbr.2014.09.002.
Conradt, E., Sheinkopf, S., Lester, B., Tronick, E., LaGasse, L., Shankaran, S., … Hammond, J. (2013). Prenatal substance exposure: Neurobiological organization at 1 month. Journal of Pediatrics, 163, 989–994. doi:10.1016/j.jpeds.2013.04.033.
Day, N., Leech, S., & Goldschmidt, L. (2011). The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning. Neurotoxicology and Teratology, 33, 129–136.
Desai, R., Hernandez-Diaz, S., Bateman, B., & Huybrechts, K. (2014). Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstetrics & Gynecology, 123, 997–1002. doi:10.1097/AOG.0000000000000208.
Fischer, G., Ortner, R., Rohrmeister, K., Jagsch, R., Baewert, A., Langer, M., & Aschauer, H. (2006). Methadone versus buprenorphine in pregnant addicts: A double-blind, double-dummy comparison study. Addiction, 101, 275–281. doi:10.111/j.1360-0443.2006.01321.x.
Fried, P., & Smith, A. (2001). A literature review of the consequences of prenatal marihuana exposure: An emerging theme of a deficiency in aspects of executive function. Neurotoxicology and Teratology, 23, 1–11.
Fried, P., & Watkinson, B. (2001). Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana. Neurotoxicolgy and Teratology, 23, 421–430.
Fried, P., Watkinson, B., & Gray, R. (2003). Differential effects on cognitive functioning in 12- to 16- year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicology and Teratology, 25, 427–436.
Fried, P., Watkinson, B., & Siegel, L. (1997). Reading and language in 9- to 12-year olds prenatally exposed to cigarettes and marijuana. Neurotoxicology and Teratology, 19, 171–183.
Goldschmidt, L., Day, N., & Richardson, G. (2000). Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicology and Teratology, 22, 325–336.
Goldschmidt, L., Richardson, G., Cornelius, M., & Day, N. (2004). Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicology and Teratology, 26, 521–532.
Goldschmidt, L., Richardson, G., Willford, J., & Day, N. (2008). Prenatal marijuana exposure and intelligence test performance at age 6. Journal of the American Academy of Child & Adolescent Psychiatry, 47, 254–263.
Gyarmathy, V., Giraduon, I., Hedrich, D., Montanari, L., Guarita, B., & Wiessing, L. (2009). Drug use and pregnancy: Challenges for public health. Eurosurveillance, 14, 33–36.
Harper, R., Solish, G., Feingold, E., Gersten-Woolf, N., & Sokal, M. (1977). Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome. American Journal of Obstetrics and Gynecology, 129, 417–424.
Hart, C., & Ksir, C. (2015). Drugs, society, and human behavior (16th ed.). New York, NY: McGraw-Hill.
Hu, S., Sheng, W., Lokensgard, J., & Peterson, P. (2002). Morphine induces apoptosis of human microglia and neurons. Neuropharmacology, 42, 829–836.
Irner, T. (2012). Substance exposures in utero and developmental consequences in adolescence: A systematic review. Child Neuropsychology, 18, 521–549. doi:10.1080/09297049.2011.628309.
Jager, G., Kahn, R., Van Den Brink, W., Van Ree, J., & Ramsey, N. (2006). Long-term effects of frequent cannabis use on working memory and attention: An fMRI study. Psychopharmacology, 185, 358–369. doi:10.1007/s00213-005-0298-7.
Jansoon, L., DiPietro, J., Velez, M., Elko, A., Knauer, H., & Tivlighan, K. (2009). Maternal methadone dosing schedule and fetal neurobehaviour. The Journal of Maternal-Fetal and Neonatal Medicine, 22, 29–35. doi:10.1080/14767050802452291.
Jansson, L., DePietro, J., & Elko, A. (2005). Fetal response to maternal methadone administration. American Journal of Obstetrics & Gynecology, 193, 611–617. doi:10.1016/j.ajog.2005.02.075.
Jansson, L., Di Pietro, J., Elko, A., Williams, E., Milio, L., & Velez, M. (2012). Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomes. Drug and Alcohol Dependence, 122, 213–219. doi:10.1016/j.drugalcdep.2011.10.003.
Jones, H. (2013). Treating opioid use disorders during pregnancy: Historical, current, and future directions. Substance Abuse, 34, 89–91. doi:10.1080/08897077.2012.752779.
Kandall, S., Albin, S., Gartner, L., Lee, K., Eidelman, A., & Lowinson, J. (1997). The narcotic-dependent mother: Fetal and neonatal consequences. Early Human Development, 1, 159–169.
Messinger, D., Bauer, C., Das, A., Seifer, R., Lester, B., Lagasse, L., … Poole, W. (2004). The maternal lifestyle study: Cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics, 113, 1677–1685.
Minozzi, S., Amato, L., Bellisario, C., Ferri, M., & Davoli, M. (2013). Maintenance agonist treatments for opiate-dependent pregnant women. The Cochrane Library, 12, 1–53.
Navaneethakrishnan, R., Tutty, S., Sinha, C., & Lindow, S. (2006). The effect of maternal methadone use on the fetal heart pattern: A computerized CTG analysis. BJOG, 113, 948–950. doi:10.1111/j.1471-0528.2006.01020.x.
Ornoy, A., Segal, J., Bar-Hamburger, R., & Greenbaum, C. (2001). Developmental outcome of school-age children born to mothers with heroin dependency: Importance of environmental factors. Developmental Medicine & Child Neurology, 43, 668–675. doi:10.111/j.1469-8749.2001.tb00140.x.
Ortigosa, S., Friguls, B., Joya, X., Martinez, S., Marinoso, M., Alameda, F., … Garcia-Algar, O. (2012). Feto-placental morphological effects of prenatal exposure to drugs of abuse. Reproductive Toxicology, 34, 73–79. doi:10.1016.jreprotox.2012.04.002.
Palchik, A., Einspieler, C., Evstafeyeva, I., Talisa, V., & Marschik, P. (2013). Intra- uterine exposure to maternal opiate abuse and HIV: The impact on the developing nervous system. Early Human Development, 89, 229–235. doi:10.1016.j.earlhumdev.2013.02.004.
Ramirez-Cacho, W., Flores, F., Schrader, R., McKay, J., & Rayburn, W. (2006). Effect of chronic maternal methadone therapy on intrapartum fetal heart rate patterns. Journal for the Society of Gynecological Investigation, 13, 108–111. doi:10.1016/j.jsgi.2005.11.001.
Richardson, G., Ryan, C., Willford, J., Day, N., & Goldschmidt, L. (2002). Prenatal alcohol and marijuana exposure: Effects on neuropsychological outcomes at 10 years. Neurotoxicology and Teratology, 24, 309–320.
Schmid, M., Kuessel, L., Klein, K., Metz, V., Fischer, G., & Krampl-Bettelheim, E. (2010). First-trimester fetal heart rate in mothers with opioid addiction. Addiction, 105, 1265–1268. doi:10.1111/j.1360-0443.2010.02982.x.
Schoeler, T., & Bhattacharyya, S. (2013). The effect of cannabis use on memory function: An update. Substance Abuse & Rehabilitation, 4, 11–27. doi:10.2147/SAR.S25869.
Schrott, L., Franklin, L., & Serrano, P. (2008). Prenatal opiate exposure impairs radial arm maze performance and reduces levels of BDNF precursor following training. Brain Research, 1198, 132–140. doi:10.1016/j.brainres.2008.01.020.
Smith, M., Costello, D., & Yonkers, K. (2015). Clinical correlates of prescription opioid analgesic use in pregnancy. Maternal Child Health, 19, 548–556. doi:10.1007/s10995-014-1536-6.
Smith, A., Fried, P., Hogan, M., & Cameron, I. (2004). Effects of prenatal marijuana on response inhibition: An fMRI study of young adults. Neurotoxiciology and Teratology, 26, 533–542.
Stanhope, T., Gill, L., & Rose, C. (2013). Chronic opioid use during pregnancy: Maternal and fetal implications. Clinics in Perinatology, 40, 337–350. doi:10.1016/j.clp.2013.05.015.
Steingart, R., Abu-Roumi, M., Newman, M., Silverman, W., Slotkin, T., & Yanai, J. (2000). Neurobehavioral damage to cholinergic systems caused by prenatal exposure to heroin or phenobarbital: Cellular mechanisms and the reversal of deficits by neural grafts. Developmental Brain Research, 122, 125–133.
Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (2009). The NSDUH report: Substance use among women during pregnancy and following childbirth. Rockville, MD: Substance Abuse and Mental Health Services Administration, Office of Applied Studies.
Villarreal, D., Derrick, B., & Vathy, I. (2008). Prenatal morphine exposure attenuates the maintenance of late LTP in lateral perforant path projections to the dentate gyrus and the CA3 region in vivo. Journal of Neurophysiology, 99, 1235–1242. doi:10.1152/jn.00981.2007.
Wahlsten, V., & Sarman, I. (2013). Neurobehavioral development of preschool-age children born to addicted mothers given opiate maintenance treatment with buprenorphine during pregnancy. Acta Paediatrica, 102, 544–549. doi:10.1111/apa.12210.
Walhovd, K., Moe, V., Slinning, K., Siquveland, T., Fjell, A., Bjornebekk, A., & Smith, L. (2009). Effects of prenatal opiate exposure on brain development – a call for attention. Nature Reviews, 10, 390. doi:10.1038/nrn2598-c1.
Walhovd, K., Slinning, V., Due-Tonnessen, P., Bjordnerud, A., Dale, A., vanderKowe, A., … Fischl, B. (2007). Volumetric cerebral characteristics of children exposed to opiates and other substances in utero. Neuroimage, 36, 1331–1344.
Walhovd, K., Westlye, L., Moe, V., Slinning, K., Due-Tonnessen, P., Bjornerud, A., … Fjell, A. (2010). White matter characteristics and cognition in prenatally opiate- and poly-substance exposed children: A diffusion tensor imaging study. American Journal of Neuroradiology, 31, 894–900. doi:10.3174/ajnr.A1957.
Welle-Strand, G., Skurtveit, S., Jones, H., Waal, H., Bakstad, B., Bjarko, L., & Ravndal, E. (2013). Neonatal outcomes following in utero exposure to methadone or buprenorphine: A national cohort study of opioid-agonist treatment of pregnant women in Norway from 1996 to 2009. Drug and Alcohol Dependence, 127, 200–206.
Winklbaur, B., Baewert, A., Jagsch, R., Rohrmeister, K., Metz, V., Jachmann, C., … Fischer, G. (2009). Association between prenatal tobacco exposure and outcomes of neonates born to opioid-maintained mothers. European Addiction Research, 15, 150–156. doi:10.1159/000216466.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Parris, L. (2016). Opiates and Marijuana Use During Pregnancy: Neurodevelopmental Outcomes. In: Riccio, C., Sullivan, J. (eds) Pediatric Neurotoxicology. Specialty Topics in Pediatric Neuropsychology. Springer, Cham. https://doi.org/10.1007/978-3-319-32358-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-32358-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-32356-5
Online ISBN: 978-3-319-32358-9
eBook Packages: Behavioral Science and PsychologyBehavioral Science and Psychology (R0)